You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
11 December 2025 - Physiomics plc (AIM:PYC), a mathematical modelling, data science and biostatistics company, said on Thursday that it has signed a new contract with Swiss biotechnology company Numab Therapeutics AG to support preclinical developmen...
11 December 2025 - Privo Technologies Inc, a US-based, late-stage clinical biopharmaceutical company, announced on Thursday that the first patient has been dosed in its first-in-human clinical trial assessing PRV131, a nanoengineered intratumoural ci...
11 December 2025 - Senhwa Biosciences Inc (TPEx: 6492), a Taiwan-based clinical-stage biopharmaceutical company, announced on Thursday that it has signed a clinical supply agreement with BeOne Medicines, a US-based global oncology company.This agreem...
10 December 2025 - Biotechnology company InduPro Inc announced on Wednesday that it has entered into a strategic equity investment and research collaboration with French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY).The agreement i...
10 December 2025 - Chinese biopharmaceutical company Innovent Biologics Inc (HKEX:01801) announced on Tuesday that that the first participant has been dosed in the Phase 1 clinical trial of IBI3011, an anti-human Interleukin 1 receptor accessory prot...
10 December 2025 - D3 Bio, a China-based global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced on Tuesday that it has completed a USD108m Series B financing round.Investors...
9 December 2025 - UK-based multinational pharmaceutical company Hikma Pharmaceuticals plc (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) announced on Monday that it has introduced the first-of-its-kind, ready-to-use vancomycin premix with room-temperatu...